Hot Features
Premium
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Period:
Draw Mode:
| Volume | 6,849 |
|
|||||
| News | - | ||||||
| Day High | 4.6344 | Low High |
|||||
| Day Low | 4.46 | ||||||
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| Palisade Bio Inc | PALI | NASDAQ | Common Stock |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| 0.04 | 0.86% | 4.68 | 15:30:00 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 4.55 | 4.46 | 4.6344 | 4.68 | 4.64 |
| Trades | Shares Traded | VWAP | Financial Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 112 | 6,849 | US$ 4.57 | US$ 31,287 | - | 3.82 - 36.60 |
| Last Trade | Type | Quantity | Price | Currency |
|---|---|---|---|---|
| 16:51:20 | 10 | US$ 4.68 | USD |
Palisade Bio Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 20.14M | 12.13M | - | 250k | -12.3M | -1.01 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Palisade Bio News
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical PALI Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 4.55 | 4.67 | 4.32 | 4.55 | 19,756 | 0.13 | 2.86% |
| 1 Month | 6.25 | 6.2886 | 4.29 | 4.94 | 32,457 | -1.57 | -25.12% |
| 3 Months | 5.5515 | 9.65 | 3.82 | 6.14 | 1,237,867 | -0.8715 | -15.70% |
| 6 Months | 8.55 | 22.35 | 3.82 | 11.09 | 1,938,676 | -3.87 | -45.26% |
| 1 Year | 24.15 | 36.60 | 3.82 | 15.19 | 1,757,587 | -19.47 | -80.62% |
| 3 Years | 3,082.50 | 3,427.50 | 3.82 | 217.08 | 1,885,949 | -3,077.82 | -99.85% |
| 5 Years | 6,750.00 | 8,182.50 | 3.82 | 353.19 | 1,882,971 | -6,745.32 | -99.93% |
Palisade Bio Description
| Palisade Bio Inc is a clinical-stage biopharma company. It is advancing oral therapies that help patients with acute and chronic gastrointestinal complications stemming from post-operative digestive enzyme damage. Palisade Bio's innovative lead asset, LB1148, is a Phase 3-ready protease inhibitor with the potential to both reduce abdominal adhesions and help restore bowel function following surgery. |
